Trial intelligence / Profile preview

PLB1004 plus platinum-based doublet chemotherapy in EGFR-mutant NSCLC

ChiCTR2500105771Phase 2Recruiting

Sponsor

Shanghai Chest Hospital

Start

Jul 2025

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1